Results 141 to 150 of about 10,145,938 (283)
Rationally engineered polymeric interfaces for selective and dynamic recognition of vesicular agents
This review explores how molecularly imprinted polymers can be engineered to recognize complex nanoscale vesicles, including extracellular vesicles and membrane‐enveloped viruses. By tailoring polymer cavities to vesicle surface chemistry and structure, these synthetic receptors support selective detection, separation, and integration with optical ...
Özgecan Erdem +4 more
wiley +1 more source
Conceptualising Cluster Evolution: Beyond the Life-Cycle Model? [PDF]
Although the literature on the evolution of industrial clusters is not vast, a preferred approach has already become evident, based around the idea of a cluster 'life-cycle'. This approach has several limitations.
Peter Sunley, Ron Martin
core
Corporate Life Cycle and Financing Decisions of Firms in Nigeria
This study examines the relationship between corporate life cycle stages and financing decisions of firms in Nigeria. Using a sample of Nigerian firms listed on the Nigerian Stock Exchange, the study finds that firms' financing decisions vary across ...
NNEKA LOVETH OFUONYEBUZOR
core +1 more source
A dual-attribution framework reveals how foreign investment and trade redistribute cobalt availability. [PDF]
Liu L +7 more
europepmc +1 more source
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley +1 more source
Big Science as Strategic Infrastructure: European Coordination, Public Value and Socio-economic Evidence. [PDF]
Crescenzi R +3 more
europepmc +1 more source
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi +3 more
wiley +1 more source
Carbon Footprint of Antibody-Based Drugs and Biologics Using Hybrid Life Cycle Assessment. [PDF]
Taillemite S +3 more
europepmc +1 more source
The components of life cycle of corporation
openaire +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source

